These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 88082)

  • 21. Inhibition of 7-dehydrocholesterol reductase by the teratogen AY9944: a rat model for Smith-Lemli-Opitz syndrome.
    Kolf-Clauw M; Chevy F; Wolf C; Siliart B; Citadelle D; Roux C
    Teratology; 1996 Sep; 54(3):115-25. PubMed ID: 8987154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refractory atypical absence seizures in rat: a two hit model.
    Serbanescu I; Cortez MA; McKerlie C; Snead OC
    Epilepsy Res; 2004 Nov; 62(1):53-63. PubMed ID: 15519132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hypocholesterolemic agents on central nervous system cholesterol biosynthesis III. Zuclomiphene in combination with AY9944 and triparanol.
    Ramsey RB
    Biochem Pharmacol; 1978; 27(12):1637-40. PubMed ID: 81057
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative teratogenic effects of triparanol in the Wistar rat and the Sprague-Dawley rat].
    Roux C; Aubry M; Dupuis R; Horvath C
    C R Seances Soc Biol Fil; 1973; 167(11):1523-6. PubMed ID: 4609570
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes of endocrine glands produced by teratogenic methods. The pituitary gland.
    Warkany J; Takacs E
    Arch Pathol; 1968 Jan; 85(1):101-13. PubMed ID: 5688695
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect in rats of simultaneous prenatal exposure to ochratoxin A and aflatoxin B1. II. Histopathological features of teratological anomalies induced in fetuses.
    Wangikar PB; Dwivedi P; Sharma AK; Sinha N
    Birth Defects Res B Dev Reprod Toxicol; 2004 Dec; 71(6):352-8. PubMed ID: 15617025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The identification of a novel C27 diene, cholesta-5,8-dien-3 beta-OL, in tissues of rats given AY-9944 (trans-1,4-bis(2-dichlorobenzylaminoethyl)cyclohexane) in pregnancy.
    Fumagalli R; Bernini F; Galli G; Anastasia M; Fiecchi A
    Steroids; 1980 Jun; 35(6):665-72. PubMed ID: 6157233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. INHIBITION OF ADRENAL CHOLESTEROGENESIS IN VITRO BY AY-9944, 22,25-DIAZACHOLESTANOL AND BY TRIPARANOL.
    GIVNER ML; DVORNIK D
    Proc Soc Exp Biol Med; 1964 Oct; 117():3-6. PubMed ID: 14219955
    [No Abstract]   [Full Text] [Related]  

  • 29. Colorimetric estimate of cholesterogenesis in livers perfused in the presence of trans-1,4-bis-(2-chlorobenzylaminomethyl)-cyclohexane dihydrochloride (AY-9944).
    Goh EH
    Biochem Pharmacol; 1979 Oct; 28(19):2969-72. PubMed ID: 92992
    [No Abstract]   [Full Text] [Related]  

  • 30. Frozen-sectioning yields similar results as traditional methods for fetal cephalic examination in the rat.
    Astroff AB; Ray SE; Rowe LM; Hilbish KG; Linville AL; Stutz JP; Breslin WJ
    Teratology; 2002 Aug; 66(2):77-84. PubMed ID: 12210011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term.
    Menegola E; Broccia ML; Nau H; Prati M; Ricolfi R; Giavini E
    Teratog Carcinog Mutagen; 1996; 16(2):97-108. PubMed ID: 8875740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EFFECT OF A NOVEL HYPOCHOLESTEROLEMIC AGENT, TRANS-1,4-BIS-(2-CHLOROBENZYLAMINOMETHYL)CYCLOHEXANE DIHYDROCHLORIDE (AY-9944) ON ADRENAL MORPHOLOGY.
    MARTON AV; GRESELIN E; GIVNER M; VOITH K
    Endocrinology; 1964 Oct; 75():469-76. PubMed ID: 14211888
    [No Abstract]   [Full Text] [Related]  

  • 33. Further observations on the teratogenic action of the thyroid stimulating hormone.
    Beaudoin AR
    Teratology; 1968 Feb; 1(1):11-9. PubMed ID: 5696814
    [No Abstract]   [Full Text] [Related]  

  • 34. Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice.
    Shinoda K; Lei H; Yoshii H; Nomura M; Nagano M; Shiba H; Sasaki H; Osawa Y; Ninomiya Y; Niwa O
    Dev Dyn; 1995 Sep; 204(1):22-9. PubMed ID: 8563022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Teratogenic action in the rat of an inhibitor of cholesterol synthesis, AY 9944].
    Roux C; Aubry M
    C R Seances Soc Biol Fil; 1966; 160(7):1353-7. PubMed ID: 4225185
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experimental and clinical aspects of Pierre Robin syndrome].
    Masi PL; Scapecchi G
    Minerva Stomatol; 1967 Jun; 16(6):387-95. PubMed ID: 4962456
    [No Abstract]   [Full Text] [Related]  

  • 37. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
    Padmanabhan R; Hameed MS
    J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marked alteration of sterol metabolism and composition without compromising retinal development or function.
    Fliesler SJ; Richards MJ; Miller C; Peachey NS
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1792-801. PubMed ID: 10393050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Teratogenic action of triparanol in mice].
    Roux C; Dupuis R
    C R Seances Soc Biol Fil; 1966; 160(5):923-8. PubMed ID: 4225098
    [No Abstract]   [Full Text] [Related]  

  • 40. Concentration-dependent effects of AY-9944 and U18666A on sterol synthesis in brain. Variable sensitivities of metabolic steps.
    Cenedella RJ
    Biochem Pharmacol; 1980 Oct; 29(20):2751-4. PubMed ID: 6159896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.